It feels like just yesterday we were talking about the nascent stages of AI regulation in the UK, and now, here we are in November 2025, with a landscape that's both more defined and, in some ways, still wonderfully complex. The UK has always prided itself on its robust regulatory environment, a reputation built on transparency and thorough scrutiny. This foundation is proving crucial as AI technologies weave themselves into the fabric of our lives.
While there aren't yet specific laws solely dedicated to AI, the existing legal and regulatory frameworks are increasingly capturing its applications. This means that many of the rules we've had for years for other purposes are now being interpreted and applied to AI. It’s a bit like finding new uses for old tools, and it’s working, albeit with its own set of challenges.
One of the persistent hurdles, as highlighted in discussions around AI governance, is a lack of absolute clarity. For many, especially smaller businesses without extensive legal teams, understanding precisely how current laws apply to their AI initiatives can feel like navigating a maze. There's also the matter of overlapping remits between different regulators, which can sometimes lead to confusion about who is responsible for what. It’s a delicate balancing act, ensuring comprehensive oversight without stifling innovation.
However, the proactive steps being taken are truly encouraging. A significant development we've seen is the establishment of the National Commission into the Regulation of AI in Healthcare. Launched by the MHRA in September 2025, this expert advisory body is a testament to the UK's commitment to safely integrating AI into critical sectors. Bringing together global AI leaders, clinicians, and regulators, its purpose is to review current regulations and forge recommendations for a new, dedicated framework for AI in healthcare, with a new framework anticipated in 2026.
This Commission isn't just looking ahead; it's also addressing immediate concerns. It's producing interim guidance on urgent areas of uncertainty, such as Ambient Voice Technology, ensuring that the healthcare system and industry have support right now. The work of the Commission is also directly supporting key government plans, like the 10-Year Health Plan for England and the Life Sciences Sector Plan, aiming to transform the NHS and boost the UK's life sciences economy.
What's particularly heartening is the MHRA's 'Call for Evidence' for the Commission. This open invitation for contributions from across the UK and internationally underscores a commitment to a truly representative and comprehensive approach. It’s a chance for everyone – from industry experts to patients – to help shape the future of AI regulation in healthcare. This call closes on February 2, 2026, so there's still time to have your say.
Chaired by Professor Alastair Denniston, a practising NHS clinician and head of the UK’s Centre of Excellence in Regulatory Science in AI & Digital Health (CERSI-AI), and co-chaired by Patient Safety Commissioner Professor Henrietta Hughes, the Commission is in excellent hands. Their collective expertise is vital in guiding how cutting-edge AI can be safely and effectively embedded into our daily healthcare experiences. Specialist working groups are also lending their domain expertise, ensuring a deep dive into specific areas.
Looking at the broader picture, the UK's approach seems to be one of measured progress. It’s about building on existing strengths, fostering collaboration, and ensuring that as AI advances, our regulatory frameworks evolve thoughtfully and inclusively. The journey is ongoing, but the direction of travel, particularly with initiatives like the National Commission, points towards a future where AI can be harnessed responsibly for the benefit of all.
